Chemical Compound

Cefazolin Impurity D

CAS Registry Number 32510-61-5
Back to search Request a Quote
Cefazolin Impurity D chemical structure
Primary Record

Cefazolin Impurity D

In stock
7,944 g
Purity
99.5 %
CAS
32510-61-5

Compound Identifiers & Properties

CAS
32510-61-5
PubChem CID
11740601
SMILES
CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CN3C=NN=N3)SC1)C(=O)O
Canonical SMILES
CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cn3cnnn3)[C@H]2SC1

Names & Synonyms

  • Cefazolin Impurity D
  • Cefazolin 3-Acetyloxy
  • 32510-61-5
  • Cefazolin EP Impurity D
  • C13H14N6O6S
  • CEFAZOLIN ACETOXY ANALOG
  • SCHEMBL10935326
  • CTK4G8808
  • EINECS 251-075-3
  • MFCD30565721
  • PIXMOMPJMIAMLJ-BXKDBHETSA-N
  • AMY27749
  • C13-H14-N6-O6-S
  • ACN-045417
  • FC63654
  • J0730018DF
  • CID11740601
  • (6R,7R)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(acetoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • SY455004
  • (6R-TRANS)-3-(ACETOXYMETHYL)-8-OXO-7-(1H-TETRAZOL-1-YLACETAMIDO)-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID
  • J319.392F
  • Cefazolin EP Impurity D(Cefazolin USP RC J)
  • CEFAZOLIN IMPURITY D (REFERENCE GRADE)
  • F19324
  • N-(TETRAZOLYLACETYL)-7-AMINOCEPHALOSPORIN
  • A899603
  • CEFAZOLIN SODIUM IMPURITY D [EP IMPURITY]
  • (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • 7-(1H-TETRAZOL-1-ACETAMIDO)CEPHALOSPORANIC ACID
  • 7-(1H-TETRAZOL-1-YL)ACETAMIDOCELPHALOSPORANIC ACID
  • B2694-468328
  • (6R,7R)-7-[2-(1H-Tetrazol-1-yl)acetamido]-3-(acetoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-, (6R,7R)-
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-,(6R,7R)-
  • (6R)-3-[(Acetyloxy)methyl]-8-oxo-7alpha-[[(1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R)-3-acetoxymethyl-8-oxo-7t-(2-tetrazol-1-yl-acetylamino)-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-3-((ACETYLOXY)METHYL)-8-OXO-7-((1H-TETRAZOL-1-YLACETYL)AMINO)-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID
  • (6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-3-[(Acetyloxy)methyl]-8-oxo-7-[[2-(1H-tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-(1H-Tetrazol-1-acetamido)cephalosporanic acid; N-(Tetrazolylacetyl)-7-aminocephalosporin
  • (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(1H-1,2,3,4-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-(2-(1H-Tetrazol-1-yl)acetamido)-3-(acetoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
  • (6R-trans)-3-(Acetoxymethyl)-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
  • 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 3-((ACETYLOXY)METHYL)-8-OXO-7-((1H-TETRAZOL-1-YLACETYL)AMINO)-, (6R-TRANS)-
  • 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 3-((ACETYLOXY)METHYL)-8-OXO-7-((2-(1H-TETRAZOL-1-YL)ACETYL)AMINO)-, (6R,7R)-
  • 7-((tetrazol-1'-yl)acetylamino)-3-acetyloxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid